Ghrelin and oxidative stress in gastrointestinal tract

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 2, 2011, Pages 122-125

  Suzuki, Hidekazu ^a   Matsuzaki, Juntaro ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastroparesis; Ghrelin; Oxidative stress; Peptic ulcer

Indexed keywords

GHRELIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CELL PROTECTION; DRUG MECHANISM; DUODENUM ULCER; GASTRIC DYSMOTILITY; GASTROINTESTINAL TRACT; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW; STOMACH MUCOSA INJURY; STOMACH PARESIS; STOMACH PROTECTION; STOMACH ULCER;

HELICOBACTER PYLORI;

EID: 79952411430     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-16GFR     Document Type: Review

References (58)

1. Selye H. The general adaptation syndrome and the diseases of adaptation. Practitioner 1949; 163: 393-405.
2. Schiavone S, Sorce S, Dubois-Dauphin M, and et al. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 2009; 66: 384-392.
3. Nagahashi S, Suzuki H, Miyazawa M, Nagata H, Suzuki M, Miura S, Ishii H. Ammonia aggravates stress-induced gastric mucosal oxidative injury through the cancellation of cytoprotective heat shock protein 70. Free Radic Biol Med 2002; 33: 1073-1081.
4. Naito Y and Yoshikawa T. Oxidative stress-induced posttranslational modification of proteins as a target of functional food. Forum Nutr 2009; 61: 39-54.
5. Ohashi Y, Aihara E, Takasuka H, Takahashi K, Takeuchi K. Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide. J Physiol Pharmacol 2009; 60: 85-93.
6. Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology 2003; 125: 1492-1502. (Pubitemid 37409770)
7. Suematsu M, Katsuki A, Sumida Y, and et al. Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects. Eur J Endocrinol 2005; 153: 403-407. (Pubitemid 41410497)
8. Zwirska-Korczala K, Adamczyk-Sowa M, Sowa P, and et al. Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. J Physiol Pharmacol 2007; 58 Suppl 1: 53-64. (Pubitemid 350022258)
9. Kyoraku I, Shiomi K, Kangawa K, Nakazato M. Ghrelin reverses experimental diabetic neuropathy in mice. Biochem Biophys Res Commun 2009; 389: 405-408.
10. Hou Y, An J, Hu XR, and et al. Ghrelin inhibits interleukin-8 production induced by hydrogen peroxide in A549 cells via NF-kappaB pathway. Int Immunopharmacol 2009; 9: 120-126.
11. Hedayati N, Annambhotla S, Jiang J, and et al. Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg 2009; 49: 199-207.
12. Xu Z, Lin S, Wu W, and et al. Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms. Toxicology 2008; 247: 133-138.
13. Huang CX, Yuan MJ, Huang H, and et al. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 2009; 30: 2286-2291.
14. Dembinski A, Warzecha Z, Ceranowicz P, and et al. Role of growth hormone and insulin-like growth factor-1 in the protective effect of ghrelin in ischemia/reperfusion-induced acute pancreatitis. Growth Horm IGF Res 2006; 16: 348-356. (Pubitemid 44774783)
15. Sibilia V, Rindi G, Pagani F, and et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144: 353-359. (Pubitemid 36076125)
16. Ceranowicz P, Warzecha Z, Dembinski A, and et al. Treatment with ghrelin accelerates the healing of acetic acid-induced gastric and duodenal ulcers in rats. J Physiol Pharmacol 2009; 60: 87-98.
17. Sibilia V, Pagani F, Rindi G, and et al. Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk. Br J Pharmacol 2008; 154: 688-697. (Pubitemid 351744947)
18. Brzozowski T, Konturek PC, Sliwowski Z, and et al. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. J Physiol Pharmacol 2006; 57 Suppl 6: 63-76. (Pubitemid 46548802)
19. El Eter E, Al Tuwaijiri A, Hagar H, Arafa M. In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 2007; 22: 1791-1799.
20. Suzuki H, Suzuki M, Imaeda H, Hibi T. Helicobacter pylori and Microcirculation. Microcirculation 2009; 1-12.
21. Iseri SO, Sener G, Yuksel M, and et al. Ghrelin against alendronate-induced gastric damage in rats. J Endocrinol 2005; 187: 399-406. (Pubitemid 43020261)
22. Suzuki H, Masaoka T, Miyazawa M, Suzuki M, Miura S, Ishii H. Gastric mucosal response to Helicobacter pylori. Keio J Med 2002; 51 Suppl 2: 40-44. (Pubitemid 36083619)
23. Suzuki H, Miura S, Imaeda H, and et al. Enhanced levels of chemiluminescence and platelet activating factor in urease-positive gastric ulcers. Free Radic Biol Med 1996; 20: 449-454. (Pubitemid 26077868)
24. Suzuki H, Mori M, Suzuki M, Sakurai K, Miura S, Ishii H. Extensive DNA damage induced by monochloramine in gastric cells. Cancer Lett 1997; 115: 243-248. (Pubitemid 27196612)
25. Suzuki H, Seto K, Mori M, Suzuki M, Miura S, Ishii H. Monochloramine induced DNA fragmentation in gastric cell line MKN45. Am J Physiol 1998; 275: G712-716.
26. Wang G, Olczak A, Forsberg LS, Maier RJ. Oxidative stress-induced peptidoglycan deacetylase in Helicobacter pylori. J Biol Chem 2009; 284: 6790-6800.
27. Suzuki H, Suzuki M, Mori M, and et al. Augmented levels of gastric mucosal leucocyte activation by infection with cagA gene-positive Helicobacter pylori. J Gastroenterol Hepatol 1998; 13: 294-300. (Pubitemid 28183961)
28. Suzuki H and Hibi T. Oxidative stress in Helicobacter pylori-associated gastroduodenal disease. J Clin Biochem Nutri 2006; 39: 56-63. (Pubitemid 44433556)
29. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007; 42: 1-15. (Pubitemid 46357245)
30. Murata Y, Matsui H, Hirano KI, and et al. Autofluorescence in indomethacin-induced gastric mucosal lesions in rats. J Gastroenterol 2000; 35: 510-517. (Pubitemid 30468456)
31. Suzuki H, Masaoka T, Hosoda H, and et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 2004; 53: 187-194. (Pubitemid 38125504)
32. Suzuki H and Hibi T. Does Helicobacter pylori attack ghrelin-producing cells? J Gastroenterol 2005; 40: 437-439.
33. Fukuhara S, Suzuki H, Masaoka T, and et al. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. Am J Physiol Gastrointest Liver Physiol 2005; 289: G138-145.
34. Suzuki H, Masaoka T, Nomoto Y, and et al. Increased levels of plasma ghrelin in peptic ulcer disease. Aliment Pharmacol Ther 2006; 24 (S4): 120-126.
35. Isomoto H, Ueno H, Nishi Y, and et al. Circulating ghrelin levels in patients with various upper gastrointestinal diseases. Dig Dis Sci 2005; 50: 833-838. (Pubitemid 40684895)
36. Suzuki H, Masaoka T, Hosoda H, and et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio - a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 2004; 51: 1249-1254. (Pubitemid 38987454)
37. Kawashima J, Ohno S, Sakurada T, and et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol 2009; 44: 1046-1054.
38. Forster J, Damjanov I, Lin ZY, Sarosiek I, Wetzel P, McCallum RW. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. Gastroenterology 2003; 124: A788-A789.
39. Masaoka T, Suzuki H, Hosoda H, and et al. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett 2003; 541: 64-68. (Pubitemid 36428918)
40. Asai S, Katabami T, Obi N, and et al. No ghrelin response to oral glucose in diabetes mellitus with gastroparesis. Endocr J 2009; 56: 79-87.
41. Gaddipati KV, Simonian HP, Kresge KM, Boden GH, Parkman HP. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci 2006; 51: 1339-1346. (Pubitemid 44315799)
42. Binn M, Albert C, Gougeon A, and et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 2006; 27: 1603-1606. (Pubitemid 43866263)
43. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 847-853. (Pubitemid 41568544)
44. Murray CD, Martin NM, Patterson M, and et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54: 1693-1698. (Pubitemid 41697666)
45. Ejskjaer N, Vestergaard ET, Hellstrom PM, and et al. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther 2009; 29: 1179-1187.
46. Wargin W, Thomas H, Clohs L, and et al. Contribution of protein binding to the pharmacokinetics of the ghrelin receptor agonist TZP-101 in healthy volunteers and adults with symptomatic gastroparesis: two randomized, double-blind studies and a binding profile study. Clin Drug Investig 2009; 29: 409-418.
47. Guzik TJ, Mussa S, Gastaldi D, and et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656-1662. (Pubitemid 34298608)
48. Richter AM, Abboud RT, Johal SS, Fera TA. Acute effect of smoking on superoxide production by pulmonary alveolar macrophages. Lung 1986; 164: 233-242. (Pubitemid 16088484)
49. Ritter C, Andrades M, Moreira JC, Dal-Pizzol F, Hussain SN. Superoxide production during sepsis development. Am J Respir Crit Care Med 2003; 167, 474; author reply 474-475.
50. Guzik TJ and Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006; 11: 524-533.
51. Nagaya N, Uematsu M, Kojima M, and et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001; 104: 2034-2038. (Pubitemid 33027043)
52. Bouros D, Tzouvelekis A, Anevlavis S, and et al. Smoking acutely increases plasma ghrelin concentrations. Clin Chem 2006; 52: 777-778.
53. Wu R, Zhou M, Cui X, Simms HH, Wang P. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. Int J Mol Med 2003; 12: 777-781.
54. Liu B, Liu X, Tang C. Change of plasma ghrelin level in acute pancreatitis. Pancreatology 2006; 6: 531-535. (Pubitemid 46360710)
55. Nagaya N and Kangawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 2003; 3: 146-151. (Pubitemid 36411238)
56. Shimizu Y, Nagaya N, Teranishi Y, and et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830-835. (Pubitemid 37188697)
57. Dembinski A, Warzecha Z, Ceranowicz P, and et al. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol 2003; 54: 561-573. (Pubitemid 38029752)
58. Chen J, Liu X, Shu Q, Li S, Luo F. Ghrelin attenuates lipopolysaccharide-induced acute lung injury through NO pathway. Med Sci Monit 2008; 14: BR141-146.